Air pollution

Air pollution

Trixeo Aerosphere Receives Positive EU CHMP Opinion as First Inhaled Medicine Using Next-Generation Propellant with Near-Zero Global Warming Potential

AstraZeneca's Trixeo Aerosphere, a pressurized metered-dose inhaler (pMDI) for chronic obstructive pulmonary disease (COPD), has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). This approval is for Trixeo Aerosphere's use of a next-generation propellant with